Lifeway Foods/$LWAY
1D1W1MYTD1Y5YMAX
Capital at risk
About Lifeway Foods
Lifeway Foods Inc is engaged in manufacturing probiotic, cultured, functional dairy health food products. Its primary product is drinkable kefir, which is a cultured dairy product. Its product categories are Drinkable Kefir, which is the key revenue-driving product, European-style soft cheeses, Cream, ProBugs, Frozen Kefir, and Other dairy. The company manufactures and markets products under the Lifeway and Fresh Made brand names, as well as under private labels on behalf of customers. It sells the products through a direct sales force, brokers, and distributors.
- Ticker
- $LWAY
- Sector
- Consumer Essentials
- Primary listing
- NASDAQ
- Employees
- 294
- Headquarters
- Morton Grove, United States
- Website
- lifewaykefir.com
Lifeway Foods Metrics
BasicAdvanced
$375M
35.86
$0.69
0.46
-
Price and volume
Market cap
$375M
Beta
0.46
52-week high
$34.20
52-week low
$17.31
Average daily volume
146K
Financial strength
Current ratio
2.094
Quick ratio
1.361
Long term debt to equity
26.412
Total debt to equity
26.564
Interest coverage (TTM)
48.39%
Profitability
EBITDA (TTM)
20.002
Gross margin (TTM)
27.18%
Net profit margin (TTM)
4.48%
Operating margin (TTM)
6.49%
Effective tax rate (TTM)
29.74%
Revenue per employee (TTM)
$820,000
Management effectiveness
Return on assets (TTM)
8.52%
Return on equity (TTM)
13.32%
Valuation
Price to earnings (TTM)
35.862
Price to revenue (TTM)
1.559
Price to book
4.43
Price to tangible book (TTM)
5.57
Price to free cash flow (TTM)
-12.145
Free cash flow yield (TTM)
-8.23%
Free cash flow per share (TTM)
-2.044
Growth
Revenue change (TTM)
25.59%
Earnings per share change (TTM)
-1.40%
3-year revenue growth (CAGR)
17.06%
10-year revenue growth (CAGR)
7.03%
3-year earnings per share growth (CAGR)
23.50%
10-year earnings per share growth (CAGR)
10.15%
What the Analysts think about Lifeway Foods
Analyst ratings (Buy, Hold, Sell) for Lifeway Foods stock.
Analyst projections of the future price of Lifeway Foods stock.
Bulls say / Bears say
Record Q2 2026 net sales of $66.9 million, a 24.1% YoY increase marking the company’s highest quarterly net sales and 27th consecutive quarter of growth. (SEC 8-K Filing)
Operating cash flow improved to $4.378 million in Q1 2026 from a net cash outflow of $0.150 million in Q1 2025, driven by increased cash earnings. (SEC Q1 10-Q)
The company remains in compliance with all financial debt covenants under its Revolving Credit Facility and had a favorable interest rate of 5.48% as of June 30, 2026, with $3.0 million available borrowing capacity. (SEC Q2 10-Q)
Gross profit margin compressed to 19.5% in Q2 2026 from 28.6% in Q2 2025, due to elevated conventional milk prices and higher resin-based packaging and transportation costs. (SEC Q2 10-Q)
Net income plunged to USD 0.127 million in Q2 2026 from USD 4.249 million in Q2 2025, highlighting thin profitability. (Reuters)
Major shareholder Danone USA PBC sold 3,454,756 Lifeway shares in May 2026 at $19.50 per share—a significant discount to market—potentially weighing on the stock and signaling reduced strategic support. (Reuters via Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2026.
Lifeway Foods Financial Performance
Revenues and expenses
Lifeway Foods Earnings Performance
Company profitability
Upcoming events
No upcoming events
Lifeway Foods News
AllArticlesVideos
Funds containing Lifeway Foods
Fund name | Fund size | $LWAY weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | €4.8B | 0.00% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.